Back

Arrhythmogenic cardiomyopathies: do we need new guidelines?

6 May 2021 (14:30 - 14:40)
Organised by:
Congress Presentation Part of: Risk stratification in cardiomyopathies Cardiac Magnetic Resonance (CMR) EACVI Premium Access EuroCMR 2021

About the speaker

Photo
Professor Martina Perazzolo Marra

University of Padua, Padova (Italy)

4 More presentations in this session

Presentation thumbnail
Cardiovascular magnetic resonance for guiding management in hypertrophic cardiomyopathy (HCM) and Fabry disease.
Professor J. Moon (London, GB)
Slides Video
Presentation thumbnail
Risk stratification in CMR in dilated / familial cardiomyopathies.
Doctor F. Alpendurada (London, GB)
Slides Video
Presentation thumbnail
Risk stratification of myocarditis.
Professor M. Friedrich (Montreal, CA)
Slides Video
Presentation thumbnail
Risk stratification in cardiomyopathies - discussion.

Access the full session

Session thumbnail
Risk stratification in cardiomyopathies
Video

The Event

Event poster

EuroCMR 2021

6 May 2021 14:30 CET
You may be interested in
thumbnail
Congress Session
Advanced imaging in heart failure
thumbnail
Webinar
The role of cardiac magnetic resonance for patients with ventricular arrhythmias and the prevention of sudden cardiac death in light of the 2022 ESC Guidelines
thumbnail
Congress Session
How to do CMR - Part 2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources